Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

December 6, 2000

Altana Inc. Recalls Desoximetasone Ointment

Melville, NY (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Altana Inc. is recalling certain Desoximetasone Ointment because of degradation failure at 12-month stability testing.

This is the first public notice of this Class III recall issued by FDA.

Desoximetasone Ointment, USP, 0.25%, in 15 and 60-gram tubes, Rx topical corticosteroid ointment, NDC #0168-0151-15 (15g) and NDC #0168-0151-60

Recall #D-048-1.

Lot #D756 EXP 11/00.

Altanta, Inc., Hicksville, New York.

Altana, Inc., Melville, New York, by letter dated October 6, 2000. Firm-initiated recall ongoing.


2,130 15-gram and 2,135 60-gram tubes were distributed; firm estimated that little or no product remained on market at time of recall initiation.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers December 6, 2000.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.